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Available online 21 December 2016Purpose: To provide imaging biomarkers of generalized spike-and-wave discharges (GSWD) in patients with
GLUT1 deﬁciency syndrome (GLUT1DS).
Methods: Eighteen GLUT1DS patients with pathogenetic mutation in SLC2A1 gene were studied by means of
Video-EEG simultaneously recorded with functional MRI (VideoEEG-fMRI). A control group of sex and age-
matched patients affected by Genetic Generalized Epilepsy (GGE) with GSWD were investigated with the
same protocol. Within and between groups comparison was performed as appropriated. For GLUT1DS, correla-
tions analyses between the contrast of interest and the main clinical measurements were provided.
Results: EEG during fMRI revealed interictal GSWD in 10 GLUT1DS patients. Group-level analysis showed BOLD
signal increases at the premotor cortex and putamen. With respect to GGE, GLUT1DS patients demonstrated in-
creased neuronal activity in the putamen, precuneus, cingulate cortex, SMA and paracentral lobule.Whole-brain
correlation analyses disclosed a linear relationship between the GSWD-related BOLD changes and the levels of
glycorrhachia at diagnosis over the sensory-motor cortex and superior parietal lobuli.
Conclusion: The BOLD dynamics related to GSWD in GLUT1DS are substantially different from typical GGE show-
ing the former an increased activity in the premotor-striatal network and a decrease in the thalamus. The re-
vealed hemodynamic maps might represent imaging biomarkers of GLUT1DS, being potentially useful for a
precocious diagnosis of this genetic disorder.
© 2016 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).Keywords:
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Absence seizure1. Introduction
Glucose transporter type I deﬁciency syndrome (GLUT1DS) is a
treatable encephalopathy, caused by a defect of glucose uptake,mediat-
ed by GLUT1, at the blood brain barrier and into brain cells due tomuta-
tions in SLC2A1 gene (solute carrier family 2 member 1) (Wang et al.,
2005). The classical phenotype includes a range of complex movement
disorders, drug-resistance epilepsy, mental retardation, and acquired
microcephaly (De Vivo et al., 1991; Seidner et al., 1998). Less severe dis-
orders mainly characterized by paroxysmal exercised-induced dyskine-
sia (PED) and ‘generalized epilepsies’, either alone or in combination,
have been reported (Arsov et al., 2012a; Striano et al., 2012; Suls et al.,tment, University of Pavia, Via
iotti).
. This is an open access article under2008, 2009). When epilepsy is the main symptom, absence seizures
(AS), mainly with early onset, seem to be the most frequent clinical ex-
pression of SLC2A1mutations and in individual cases ASmay be pheno-
typically indistinguishable from absences of the genetic generalized
epilepsies (GGE; formerly known as idiopathic generalized epilepsies)
(Arsov et al., 2012a; Mullen et al., 2010; Striano et al., 2012). Further-
more, during childhood, the most common EEG abnormalities are 2,5–
4 Hz generalized spike and wave discharges (GSWD) (Leary et al.,
2003). This pattern is usually more polymorphic and irregular that the
classic 3-Hz spike-wave (Leary et al., 2003), but could be likewise simi-
lar and elicited by hyperventilation. Given this combination of EEG fea-
tures and seizure type, GLUT1DS should be considered in the differential
diagnosis of childhood (CAE) or juvenile absence epilepsy (JAE), partic-
ularly if atypical features are present (Byrne et al., 2011). Myoclonic-
astatic and myoclonic absences epilepsy phenotypes have been also re-
ported (Larsen et al., 2015;Mullen et al., 2011). A chronicmetabolic dis-
turbance caused by lowered glucose transport is considered to bethe CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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tients with GLUT1 deﬁciency (Pascual et al., 2002; Seidner et al., 1998).
This study is the ﬁrst investigation of the brain networks involved in
the generation of GSWD in GLUT1DS by means of EEG co-registered
with fMRI (EEG-fMRI). In particular, we aimed to isolate the BOLD cor-
relates of GSWD in GLUT1DSwith respect to the ones typically observed
in GGE (Benuzzi et al., 2012; Gotman et al., 2005;Moeller et al., 2008; Li
et al., 2009). This objective could be relevant for the following reasons:
(a) to better understand the pathophysiology GLUT1DS; (b) to provide
imaging biomarkers of the disorder that might orient the diagnosis; (c)
to evaluate themechanisms of ‘generalized’ SWD in a model not due to
a channelopathy.
2. Materials and methods
2.1. Patients
Eighteen Italian GLUT1DS patients (mean age 19,22 years; range 6–
43 years; 12 females) were enrolled from September 2012 to March
2015. The recruited subjects fulﬁlled the clinical criteria for diagnosis
of GLUT1DS (Pearson et al., 2013) and all but one presented pathogenic
mutations in SLC2A1 gene (Table 1).
The clinical, molecular methods and genetic features of this
GLUT1DS cohort have been previously described (De Giorgis et al.,
2015; Gagliardi et al., 2012; Ragona et al., 2014; Veggiotti et al., 2010;
Zorzi et al., 2008). Brieﬂy, mutation analysis of all exons and intron-
exon boundaries of SLC2A1 was performed on genomic DNA by direct
sequencing. Each fragment was sequenced on both strands. The effect
of the newly detected SLC2A1 mutations on protein structure or func-
tion was analyzed with the prediction programs ExPASy (http://www.
expasy.org).
The mean age at diagnosis was 16,2 ± 11,1 years. Structural MRI
scan (3T) was normal in all cases. All patients but 2 (#6; #18) experi-
enced epileptic seizures (mean age of seizure onset was 34 ±
21 months). The most representative seizure's type was AS (10 out of
18 patients) followed by generalized tonic-clonic and myoclonic sei-
zures. Notably, four patients had AS alone and one patient hadTable 1
Clinical feature and genetic of GLUT1 patients.
Pt
ID
Age(yrs)/sex Age at diagnosis
(yrs)
Glycorrhachia
(mg/dl)
CSF/plasma
glucose ratio
Protein
mutation
1 12/M 6 35 0.54 c1457delG
delG SPL
2 11/F 10 33 0.34 R126C
3 14/M 11 44 0.51 R223W
4 9/F 5 31 0.39 R153C
5 12/M 10 40 0.47 R458W
6 10/F 10 33 0.38 V165I
7 7/F 7 32 0.35 N34S
8 12/F 9 34 0,38 R400C
9 6/F 5 40 0,41 not found
10 27/F 20 31 0.38 R126C
11 18/F 14 40 0.44 P36R
12 28/M 17 46 0.54 R458W
13 43/F 43 N/A N/A R458W
14 40/F 29 41 0.44 V165I
15 24/F 24 N/A N/A V165I
16 19/F 19 38 0,5 1166delV
17 39/M 39 42 0.43 N34S
18 15/M 15 44 0,44 R400H
Legend Table 1: M: Male; F: Female; A; Ataxia; AS: absences seizures; Cho: chorea; Dy: Dystoni
not available; PED: paroxysmal exercise-induced dyskinesia. LEV: Levetiracetam; LTG: Lamotri
genic diet. S: sporadic; F: familiar.
Missense mutations were observed in the majority; case #1 and n #16 presented deletions. A
amino acid number, andmutant amino acid. Nucleotide deletions are indicated bynucleotide numyoclonic seizures without movement disorders. Eleven out of 18
GLUT1 subjects presented complex movement disorders, like ataxia,
dystonia, chorea and paroxysmal exercise-induced dyskinesia. An intel-
lectual impairment of variable degree was detected in 8 patients (ac-
cording to the Diagnostic and Statistical Manual of Mental Disorders-
DSM V). The rest of the sample displayed normal intellectual abilities,
although for most of them the IQ was in the low range of normality.
Seven out of the patients were on ketogenic diet either at different reg-
imens alone (patients #4, #6, #11) or in combination with antiepileptic
drugs (#2, #8, #10, #18).
A group of 18 patients with GGE served as control (mean age
24,88 years; range 5–48 years; 12 females). Patients were extracted
from our database of GGE patients who underwent an EEG-fMRI study
between April 2007–December 2013. The patients' inclusion criteria
were the followings: 1) documented GSWD with AS during routinely
video-EEG monitoring; 2) routine EEG showing normal background;
3) normal developmental milestones; 4) normal structural imaging on
anatomic MRI at 3T. The GGE syndromes classiﬁcation was obtained
by two expert epileptologists after a careful revision of clinical and elec-
trophysiological data of each patient (S.M., A.E.V.) according to the ILAE
classiﬁcation (1981). Table 2 summarizes the clinical and EEG ﬁndings
of GGE population.
The human ethic committee of the University of Modena and Reggio
Emilia approved this study and written informed consent was obtained
from all the patients and from their parents if underage.
2.2. EEG with fMRI recordings and analysis
Video-EEG signals have been recorded by means of a 32 channels
MRI compatible EEG recording system (Micromed, Italy). Patients
were asked to rest with eyes closed and keep still. All recordings were
performer in the early afternoon. Sedation was never used. After the
fMRI acquisitions, both GLUT1DS and GGE patients were interviewed
for discomfort or any clinical, even subjective, ictal events while
scanning.
fMRI data (30 axial slices, TR/TE= 3000/50ms) have been acquired
using a 3T scanner (Philips) over three 10-min sessions (200 volumes/Seizure
type
Seizure onset
(mo)
Sporadic/Familiar Motor
Signs
IQ Treatment at
fMRI
_1 GTC, AS 11 S PED, Dy 75 VPA
Myo, AS 30 S PED, Dy 44 LEV, LTG, 3:1
KD
FS 11 S PED, Cho 75 OXC
GTC, AS 12 F A 104 1.8:1 KD
FS 40 F PED, Cho 85 VPA
/ / F PED, Dy,
Cho
66 3:1 KD
AS 24 F / 76 ETS
AS, Myo 36 S PED, Dy 50 LTG, 3:1 KD
Myo,
GTC
39 S / 112 VPA, LTG, CLB
AS, FS
Myo
8 S PED, A 60 LEV, 3:1 KD
AS 18 S / 53 2,5:1 KD
FS 60 S PED, Dy 57 ETS
AS 72 F / 78 –
AS, GTC 12 F PED 55 VPA
AS 72 F / 76 –
AS 48 S PED. Dy 80 LTG
AS 48 F PED, Dy 75 CBZ
/ / S PED, Dy 56 VPA, 3:1 KD
a; GTC: generalized tonic clonic seizures; FS: focal seizures; Myo:Myoclonic Seizures; N/A:
gine; VPA: Valproate; ETS: Ethosuximide; CBZ: Carbamazepine; CLB: Clobazam; KD: keto-
mino acid mutations are represented by (capital) native amino acid (in one-letter code),
mber, del for deletion, nucleotide, or by native nucleotide, number, andmutant nucleotide.
Table 2
GGE population: clinical features and details of the EEG data during fMRI.
Clinical Data GSWD during fMRI
Pts ID Age (years)/sex Epilepsy syndrome AEDs N° events Mean duration (sec) Minimum Duration (sec) Maximum Duration (sec)
1 24/F JAE LEV 45 3,24 1,5 5,4
2 33/F JAE VPA 15 3,61 0,8 6,8
3 47/M JAE VPA 21 3,71 2 5
4 48/F CAE VPA 14 4,03 1,2 6,1
5 26/M Adult onset IGE PB/TPM/ZNZ 12 4,99 2 7
6 37/F JAE LEV 19 3,91 1,6 8,1
7 14/F JAE VPA 16 3,18 1,1 6,9
8 23/F Adult onset IGE LEV 3 3,07 0,9 5
9 5/F CAE Naïve 5 5,20 2,2 7
10 20/F JAE Naïve 9 3,14 1,1 5,2
11 12/M CAE Naïve 5 7,29 2,2 10
12 9/F CAE Naïve 3 7,63 1,1 15
13 11/M JAE VPA 9 5,19 3,1 7,6
14 10/F CAE Naïve 6 5,07 2,2 6,9
15 41/F Adult onset IGE LEV 47 2,13 1 5
16 35/F JAE VPA 15 2,45 2,2 3,6
17 15/M JME LEV 8 3,40 2,1 4,4
18 38/M JAE VPA 41 3,74 1.7 6,6
Legend Table 2: M: Male; F: Female; JAE: juvenile absence epilepsy; CAE: childhood absence epilepsy; GGE: genetic generalized epilepsy; JME: juvenile myoclonic epilepsy; AEDs: anti-
epileptic drugs; VPA: valproate; LEV: levetiracetam; PB: phenobarbital; TPM: topiramate; ZNZ: zonisamide; GSWD: generalized spike-wave discharge.
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resolution T1-weighted anatomical image was obtained for anatomical
reference (170 sagittal slices, TR/TE = 9.9/4.6 ms).
After ofﬂine correction of the gradient artifacts and ﬁltering of the
EEG signal (Allen et al., 2000), the EEG data were reviewed and pre-
processed according to our previous published method (Avanzini et
al., 2014; Ruggieri et al., 2015). Two experienced electroencephalogra-
phers reviewed the pre-processed EEG recordings independently
(A.R., P.V.) in order to identify GSWD. After identiﬁcation, epileptiform
activities were manually marked on EEG and exported as single event
or variable-length blocks depending on their duration observed by EEG.
The Matlab 7.1 and SPM8 (http://www.ﬁl.ion.ucl.ac.uk/spm/) soft-
ware was used for data analysis. All functional volumes were slice
time corrected, realigned to the ﬁrst volume acquired, spatial normal-
ized and smoothedwith 8 × 8 × 8mm full-width half maximumGauss-
ian Kernel. Movement artifacts individuated by analysis of Video-EEG
recordings (blinking, lip smacking, swallowing, head movements)
were considered as confounders in the model and treated as stick func-
tions or blocks as appropriated (Ruggieri et al., 2015). In addition, 24 re-
alignment parameters [six scan realignments parameters from image
pre-processing and a Volterra expansion of these (Friston et al., 1996)]
were included in the model as confounds.
2.2.1. First level analysis
Maps of the t-statistic were created using the timing of the GSWD as
events (stick functions or blocks)within theGeneral LinerModel (GLM)
framework. In case of blocks, the duration of GSWDwas speciﬁed. All re-
gressors were convolved with the canonical hemodynamic response
function (HRF) plus its temporal and dispersion derivatives (Lemieux
et al., 2008).
2.2.2. Group level analysis
The effect of GSWD at the group level was tested for GLUT1DS and
GGE patients separately by means of the ﬁxed-effect or the random ap-
proach as appropriate (Friston et al., 1999).When using the ﬁxed-effect
model, a conjunction analysis of the BOLD increases and decreases ef-
fects for all the subjects was done with global null hypothesis, to evalu-
ate whether the selected congruent contrasts were consistently high
and jointly signiﬁcant (Friston et al., 1999). For the random effect anal-
ysis, a full factorial design was used to test for within effects (1-way
analysis of variance [ANOVA]) with 1 group of patients (18 GGE) and
three basis functions (canonical HRF and its derivatives) as factors.
Group analysis results were considered signiﬁcant at the p b 0.05corrected for FWE or, if any results were revealed, a less conservative
statistical inference was considered (p b 0.001, uncorrected). In these
cases, an additional threshold of 5-voxels extent was applied in order
to discard BOLD changes occurring in scattered voxels. The fMRI t-
maps were superimposed on the canonical T1-weighted images as im-
plemented in SPM8.
Subsequently, we compared the BOLD changes obtained in the two
populations in order to isolate the GSWD-related hemodynamic pat-
terns speciﬁc of the two epileptic conditions. To this end, 10 age and
sex matched GGE patients were extracted from the whole GGE sample
(patient #7, #9, #10, #11, #12, #13, #14, #15, #17, #18). Within this
subgroup, a total number of 149 GSWD were recorded (mean duration
4,59 s). A single ﬁxed effect analysis that included both groups in one
matrix (10 GLUT1DS and 10 GGE) was performed. The GSWD effect
across the 10 GGE patients was obtained using ﬁxed effect approach
with conjunction analysis (Friston et al., 1999) similar towhat previous-
ly described for GLUT1DS. Further, we explored the differences by ap-
plying an exclusive masking procedure between the conjunction
contrasts each related to the speciﬁc patients' populations. In details,
to isolate the brain regions that were signiﬁcantly involved in the
main effect “GSWD N baseline” in GLUT1DS population but not in the
main effect “GSWD N baseline” in GGE, the conjunction contrast
“GSWD N baseline” in GLUT1DS was exclusively masked by the mask
conjunction contrast “GSWD N baseline” in GGE. By counterpart, to iso-
late the brain regions exclusively activated by GSWD in GGE, the con-
junction contrast “GSWD N baseline” in GGE was exclusively masked
by the conjunction contrast “GSWD N baseline” in GLUT1DS. SPM exclu-
sive masks were thresholded at p b 0.05 uncorrected, whereas the con-
trasts to be masked were thresholded at p b 0.001. In this way, those
voxels that reached a level of signiﬁcance at p b 0.05 in the mask con-
trast were excluded from the analysis.
Finally, for the GLUT1DS patient group only, we performed addition-
al whole brain second-level correlations analyses between the contrast
(GSWD) and the main clinical measurements including: age (years);
age at seizure onset (months); total IQ; glycorrhachia values (mg/dl)
and the CSF/plasma glucose ratio at the time of diagnostic workup.
We also explored the effect of the ketogenic diet (KD) on the GSWD-re-
lated BOLD changes. Indeed, ﬁve GLUT1DS patients (#6, #8, #10, #11,
#18) were on KD (alone or with antiepileptic treatment-AED) (KD+)
at the time of the fMRI study, while the remaining were naïve (#13)
or only under AED (#3, #5, #9, #17) (KD-). In a separate analysis, we
have performed a conjunction analysis, based on the ﬁxed effect
model, of the GSWD-related T contrast in the KD+ subgroup and then
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were explored by applying an exclusive masking procedure at a thresh-
old of p b 0.05, uncorrected for multiple comparisons.
3. Results
3.1. EEG ﬁndings during fMRI
In GGE, EEG during fMRI shown symmetric and synchronous gener-
alized 3–4 Hz SWD in all the patients. A total of 293 events (mean of 17
events per subject) were acquired, from a minimum of three GSWD in
subject #8 and #12, to a maximum of 47 events in subject #15. The du-
ration of GSWD ranged from 1 s to 15 s, with a mean duration across
subjects of 4.2 s (see Table 2). The GSWD occurrence was not accompa-
nied by clinical manifestations, even subjective, in any patients.
In GLUT1DS, EEG during fMRI revealed SWD in 10 subjects. Six pa-
tients (#3, #5, #6, #9, #11, #17) presented 3–4 Hz diffuse spike-and-
waves discharges; four patients showed more focal discharges over
the bilateral frontal leads (#8, #10, #13, #18). A total number of 152
SWD were recorded (range: 6–28). The duration of GSWD ranged
from 1 s to 18 s, with a mean duration across GLUT1DS of 4,31 s (see
Table 3). Fig. 1, panel A shows the EEG pattern in a representative case
(#10). The GLUT1DS patients did not shown any clinical seizures,
even subtle or subjective, during the EEG-fMRI. In addition, no persis-
tent or paroxysmal movement disorders (dystonia, dyskinesia, chorea)
were recorded during the experimental sessions.
For both GLUT1DS and GGE populations, the absence of clinical
events (seizure and movement disorder) was veriﬁed by either the in-
spection of the Video recorded simultaneously during fMRI acquisitions
and the post-scanning individual patient's interview.
3.2. GSWD related BOLD changes in GLUT1DS
Table 3 summarizes the fMRI ﬁndings at single subject level. GSWD-
related hemodynamic changes were distributed homogenously across
patients, revealing the involvement of the same cortico(frontal)-Table 3
EEG and fMRI results at single-subject level.
PT
ID
ED Bold changes
Type and
location
Number/mean
duration (sec)
Minimum
duration (sec)
Maximum
duration (sec)
Basal
Ganglia
Front
operc
Pt3 B F SWD 12/11,89 2,68 18,1 B (NR)
(3.51) (i)
B (NL
(4.94)
Pt5 Diffuse
SWD
6/2,1 1 3.24 – B(NR)
(4.82)
Pt6 Diffuse
SWD
12/2,17 0,36 4,53 B (NL)
(2.58) (i)
–
Pt8 B F SWD
(NL)
11/2,14 0 4.01 – –
Pt9 Diffuse
SWD
15/3,2 0 15.24 L (2.72)
(i)*
–
Pt10 B F SWD 18/4,28 1 17,84 B (NL)
(4.86) (i)
B(NL)
(3.99)
Pt11 Diffuse
SWD
15/1,34 0 2,05 – B (4.9
(i)
Pt13 B F SWD 28/3,6 0 15,8 L (3.82)
(i)*
B (NR
(5.67)
Pt17 Diffuse
SWD
10/3 1 4,5 – –
Pt18 B F SWD 25/3,5 1 8,4 – –
Legend Table 3: FMRI results are displayed using a threshold set at p b 0.05 corrected for FWE a
tistical inference (the results obtained using a p b 0.001 uncorrected are indicated by the asterisk
SlowWaves; SWD: spike-wave discharges; L: Left; R: Right; B: Bilateral; F: Frontal; TP: Tempor
SMA: Supplementary Motor Area; **DMNp: Default-mode Mode Network which includes: possubcortical(basal ganglia) network. In particular, all GLUT1DS demon-
strated BOLD changes at a frontal network, encompassing premotor
(prefrontal cortex, supplementary motor area-SMA, cingulate cortex)
(9 patients) and motor brain regions (5 subjects). The frontal BOLD re-
sponse was positive in all the cases except four patients (#6, #8, #13,
#18). Subcortical positive hemodynamic changesweremainly conﬁned
at the basal ganglia (putamen) (5 patients) while only one patient
(#13) demonstrated thalamic BOLD signal increases. Finally, 7 GLUT1DS
demonstrated signiﬁcant BOLD responses at the posterior part of the
Default Mode Network, essentially as signal increases (6 subjects). Fig.
1, panel B shows the GSWD-related fMRI map in a representative case
(#10).
At the group-level, ﬁxed effect analysis (p b 0.05 corrected for FWE)
showed BOLD positive changes over the bilateral premotor cortex
(global maxima-GM) (Brodmann Area-BA9), precuneus (BA7), inferior
frontal gyrus (BA46) and SMA (BA6), while decreases involved the bi-
lateral motor cortex (BA2) and the pericentral lobule (BA5) (Fig. 2A).
At a less conservative threshold (p b 0.001 uncorrected) a bilateral tha-
lamic deactivation was detected. The conjunction analysis (p b 0.001
uncorrected) revealed commonalities in BOLD signal increases between
the ten subjects in the bilateral premotor cortex (GM) and right puta-
men; negative BOLD changes were detected in the thalamus, primary
motor cortex, inferior frontal gyrus. The BOLD increase in the premotor
cortex survived at amore conservative threshold (p b 0.05 corrected for
FWE) (Fig. 2B).3.3. GSWD-related BOLD changes in GGE
At the group level (n. of patients = 18), random effect analysis
(p b 0.05 corrected for FWE) revealed BOLD signal increases in the bilat-
eral thalami (GM) and cerebellum, while negative changes were ob-
served in the posterior part of the Default Mode Network (DMN)
encompassing the bilateral precuneus (BA7), and inferior parietal lobule
(BA40) (Supplementary Fig. 1). When the analysis was limited to 10
GGE, the conjunction approach based on the ﬁxed-effect modelal
ulum
Premotor
cortex
SMA Cingulate
cortex
Pericentral
cortex
DMN** Other
)
(i)
B (NR)
(5.07) (i)
L (4.50)
(i)
– – L (4.90)
(i)
–
(i)
R (4.88)
(i)
– – – – –
L (3.46)
(d)*
B (NL)
(2.89)
(d)*
B (NL)
(3.82)
(d)*
– B cerebellum
(2.99) (d)*
R (d)* – – – –
R (4.35)
(i)
L (3.02)
(i)*
– B (NR)
(3.75) (i)*
B (NR)
(4.30) (i)*
B cerebellum
(4.32) (i)
(i)
B (NR)
(N7.59)
(i)
B (NL)
(N7.59)
(i)
L (N7.59)
(i)
B (NL)
(6.35) (i)
L (5.07)
(i)
–
2) – B (4.94)
(i)
– – B (6.15)
(i)
–
)
(d)
B (NR)
(6.41) (d)
B (NR)
(7.81) (d)
B (NL)
(7.81) (d)
B thalamus
(4.40) (i)*
B cerebellum
(4.12) (i)*
– – B (NR)
(3.32) (i)*
B (NR)
(3.17) (i)*
L TP junction
(i)
B (5.39)
(d)
– – – R (3.77)
(i)*
–
nd p b 0.001 uncorrected if no BOLD changes were detected at the more conservative sta-
[*]). The numbers in brackets indicate themaximal t-values. ED: epileptic discharges; SW:
o-Parietal. (i) increase BOLD signal; (d) decrease BOLD signal; L: Left; R: Right; B: Bilateral;
terior part of DMN (precuneus/posterior cingulate, bilateral inferior parietal lobuli).
Fig. 1. EEG-fMRI results in a representative GLUT1 patient. Panel A: Representative EEG recorded during fMRI acquisition in patients #10. The EEG is displayed in bipolar montage after
gradient and pulse artifact correction. Note the burst of 1.5–2 Hz SWD over the bilateral frontal ﬁelds. Panel B: fMRI results (p b 0.05 corrected for FWE) overlaid to the canonical T1
image, axial, coronal and sagittal slice. Signiﬁcant BOLD signal increases were detected at the bilateral middle frontal gyrus (global maxima) (BA6), supplementary Motor Area (SMA)
(BA6), putamen, post-central cortex (BA40), inferior frontal gyrus (BA9), left anterior cingulate cortex (BA32), left precuneus (BA19). No BOLD decreases were detected. R = Right;
L = Left; BA: Brodmann Area.
450 A.E. Vaudano et al. / NeuroImage: Clinical 13 (2017) 446–454revealed commonalities in BOLD signal increases in the bilateral thalami
(more right) and cerebellum.
3.4. GLUT1 versus GGE
GLUT1DS patients demonstrated during GSWD increased neuronal
activity in the bilateral putamen, precuneus, middle cingulate cortex,
right SMA and right paracentral lobule, while GGE do not (Fig. 3A). On
the contrary, no GGE-exclusive GSWD-BOLD correlates were observed
at the considered threshold.
3.5. Correlations between BOLD signal and clinical measures
Whole-brain correlation analyses using individual clinical character-
istics of the GLUT1DS patients disclosed a linear positive relationship
between the interictal discharges - related BOLD changes and the levels
of glycorrhachia (and also CSF/plasma glucose ratio) over a bilateral cor-
tical network including the opercular-insular cortex, the post-central
cortex and superior parietal lobuli (Fig. 3B). No signiﬁcant correlations
were discovered with the age, age at seizure onset, and the total IQ.
The conjunction analysis limited to KD+patients (p b 0.001, uncorrect-
ed for FWE) demonstrated common BOLD positive responses over the
bilateral precuneus, bilateral inferior parietal lobule, right precentral
gyrus and a small spot in the left putamen (data not shown). No nega-
tive responses were detected. The comparison between the hemody-
namic changes in GLUT1DS KD+ versus KD-, did not isolated anyBOLD cluster speciﬁc of GLUT1DS KD+ and viceversa, at the considered
threshold.
4. Discussion
This work represents the ﬁrst attempt to investigate the hemody-
namic correlates of interictal epileptiform activity (IED) in a cohort of
patients with GLUT1DS. To note, previous functional neuroimaging
studies in these patients (Akman et al., 2015; Pascual et al., 2002,
2007; Suls et al., 2008) were unable to obtain the EEG recordings at
the time of imaging and the interictal/ictal state was assessed only by
clinical inspection. In our study, the video-EEG recorded simultaneously
during fMRI acquisitions allowed both to record the cerebral brain
activity and to exclude the presence of any clinical seizure as well as
paroxysmal movement disorder during the experimental sessions.
Consequently, the resulted maps represent a real-time picture of brain
function during IED in GLUT1DS.
The studied population is representative of the complex pheno-
typical spectrum of the disorder and particularly with early onset ab-
sence seizures as the main seizure type (Arsov et al., 2012b; Byrne et
al., 2011; Leary et al., 2003; Striano et al., 2012; Wang et al., 2005)
and paroxysmal exertion-induced dystonia (PED) as most frequent
movement disorder (Suls et al., 2008). However, epilepsy and
motor signs were not homogenously distributed across patients as
well as treatment and age at the time of the fMRI study. This hetero-
geneous presentation reﬂects the intrinsic and natural variability
of the syndrome, as largely documented (Brockmann, 2009; De
Fig. 2. Results of SWD-related second level analysis in GLUT1DS. Panel A: FFX {T} BOLD signal changes across the 10 GLUT1DS with recorded SWD. Positive (in red) and negative (in blue)
BOLD responses are displayed onto the T1-canonical image, axial slices (p b 0.05 corrected for FWE). See text for a description of positive and negative BOLD correlations. Panel B:
Conjunction analysis results (p b 0.001, uncorrected) shown common areas of positive and negative BOLD correlation with the SWD across the 10 GLUT1DS subjects. L = Left; R= Right.
451A.E. Vaudano et al. / NeuroImage: Clinical 13 (2017) 446–454Giorgis and Veggiotti, 2013; De Giorgis et al., 2015; Verrotti et al.,
2012). The clinical variability of GLUT1DS represents a difﬁculty to
diagnose the disorder, especially for patients with mild or non-clas-
sical phenotype, who are likely to be under-diagnosed (Brockmann,
2009; De Giorgis et al., 2015). In this contest, the present work
might be of importance to underlie the pathophysiological ﬁnger-
prints of this metabolic encephalopathy.
As far as the fMRI analyses, the results of our work are innovative for
twomain aspects. Firstly, the observed BOLD ﬁndings allowed delineat-
ing a well-deﬁned network of cortical-subcortical regions that areinvolved in the generation of GSWD in GLUT1DS. The results at the sec-
ond level analysis showed an increase BOLD signal, and hence an in-
creased neuronal activity, in the premotor-striatal network (bilateral
premotor cortex, SMA, anterior cingulate and basal ganglia) and a si-
multaneous reduced metabolic demand of the motor cortex and thala-
mus. Notably, the analysis of single-subject GSWD-related BOLD
changes was consistent with the group results as most of the patients
showed signiﬁcant BOLD changes within the premotor-basal ganglia
circuit (see Table 3). The altered metabolism of thalamus and cortico-
striatal pathways found in our patients speaks to the severe abnormality
Fig. 3. Speciﬁc BOLD response to GSWD in GLUT1DS and correlation with clinical variables. Panel A: the main effect conjunction contrast “GSWD N baseline” in GLUT1DS was exclusively
masked by the mask conjunction contrast “GSWD N baseline” in GGE, at a threshold of p b 0.05, uncorrected for multiple comparison. GSWD-related BOLD signal increases speciﬁc to
GLUT1DS were detected at the bilateral putamen, precuneus (BA31), middle cingulate cortex (BA32), SMA (BA6) and right paracentral lobule (BA5). Clusters of activation are overlaid
on the canonical T1-weighted structural scan. Panel B: A linear correlation between BOLD changes and levels of glycorrhachia is evident in GLUT1DS. The results are displayed onto
canonical render images (p b 0.001, uncorrected). The graph demonstrated the positive correlation between the two variables (right image). L = Left; R = Right, BA: Brodmann Area.
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the central epileptogenic substrate in GLUT1DS.
As second main result, our ﬁndings shown that the BOLD dynamics
related to GSWD in GLUT1DS are substantially different from the
BOLD correlates of GSWD in typical genetic generalized epilepsies
(Aghakhani et al., 2004; Benuzzi et al., 2012; Carney et al., 2010;
Gotman et al., 2005; Hamandi et al., 2006; Li et al., 2009; Moeller et
al., 2010; Vaudano et al., 2009), reinforcing the hypothesis of a speciﬁc
relationship with the GLUT1DS disorder. Intriguingly, the cortical net-
works observed in GLUT1DS patients are very similar to the one de-
scribed, by means of EEG-fMRI, in patients with ‘Doose syndrome’ or
Myoclonic Astatic Epilepsy (MAE) (Moeller et al., 2014). This common-
ality is of particular interest since MAE has been reported as one of the
possible phenotypes of GLUT1DS (Mullen et al., 2011). With respect to
the BOLD ﬁndings previously reported in MAE (Moeller et al., 2014),
and more in general to GGE sub-syndromes, our GLUT1 population
didn't show any increase in BOLD signal at thalamic level and no de-
creases in the Default Mode Network (DMN) at a group level. By con-
trast, GLUT1DS revealed bilateral activation in the putamen and
different premotor and parietal areas (Fig. 3A); this pattern in notgenerally reported in GGE, except for single cases description (see
Carney and Jackson, 2014 as review). The consistency of 3–4 Hz
GSWD associated hemodynamic changes in GGE across studies, further
support that themechanisms subserving GSWD generation in GLUT1DS
involve different neural dynamics. The irregular and slower phenotype
of GSWD in GLUT1DS might partially explain these BOLD differences.
Nevertheless, previous evidences failed to detect speciﬁc hemodynamic
pattern linked to different GGE subgroups, independently to the mor-
phology and length of GSWD (Pugnaghi et al., 2014).
The revealed hemodynamic changes in GLUT1DS are concordant
with ﬁndings observed by means of positron emission tomography
(PET) imaging in humans (Akman et al., 2015; Pascual et al., 2002–
2007; Suls et al., 2008). Overall considered, interictal 18F-
ﬂuorodeoxyglucose PET demonstrated a relatively homogeneous pat-
tern with glucose hypometabolism in the mesial temporal regions,
pre-postcentral gyrus, premotor cortex, inferior parietal lobule and thal-
amus, and a relative increased in the basal ganglia (putamen). These PET
ﬁndings demonstrated to be stereotyped regardless of disease severity,
or type and duration of therapy, and persist into adulthood (Pascual et
al., 2002–2007). In other words, hypometabolism pattern may not
453A.E. Vaudano et al. / NeuroImage: Clinical 13 (2017) 446–454show a progressive changes with increasing age or clinical course of sei-
zures (Akman et al., 2015). This argument is concordant with our fMRI
ﬁndings, as similar BOLD patterns were observed in adults and children
and no relationship has been detected between age and IED-related he-
modynamic changes. To note, we observed that BOLD signal related to
epileptic discharges at the time of fMRI correlated with the level of
CSF glucose at the time of diagnosis (Fig. 3B). This means that the
lower the CSF glucose in early childhood, the lower are the BOLD signal
changes IED-related, several years later at the timeof the imaging study.
Such linear correlation is particularly evident at the bilateral sensory-
motor and parietal circuits which neuronal activity is highly dependent
to the glucose supply especially in early infancy (Chugani, 1998). This
ﬁnding supports the observations of Akman et al. (2015)who suggested
“that brain glucose hypometabolism, present in infancy, leaves an im-
print that persists even when the precipitating condition causing the
hypoglycorrachia is corrected”. Probably, hypoglycorrachia during a
vulnerable period in early infancy can affect the maturation of the de-
veloping striatal-thalamo-cortical networks and synaptic connections,
leaving a persistent alteration even when hypoglycorrhachia is
corrected. As far as the correlation between the GSWD-related BOLD
changes and other clinical variables, no relationship was detected with
the type of treatment, particularly in relation to the presence/absence
of KD (KD+ versus KD-). Such inconclusive result needs to be taken
with caution given the low number of patients in each subgroup. A fur-
ther dedicated study on a larger cohort of GLUT1DS patients with IED
during fMRI scanning and different treatments (KD and/or AED) needs
to be performed to test the speciﬁc effect of KD on the brain networks
function in GLUT1DS.
Our fMRI results demonstrated that the disruptedmetabolism of the
premotor-basal ganglia circuit is responsible for the generation and
maintenance of interictal GSWD. Since we did not record any clinical
seizure as well as involuntary movements during the experimental ses-
sions, we could not directly link the detected hemodynamic changes
with these clinical phenomena. Previous attempts to segregate the
PET patterns based on the GLUT1DS clinical phenotype shown that a
prominent hypometabolism in the thalamus and mesial temporal cor-
tex linked to the presence of epilepsy (Akman et al., 2015) while PED
frequency score was positively correlated to the metabolic activity of
basal ganglia (putamen), and negatively with the premotor cortex (an-
terior cingulate and superior frontal cortex) (Suls et al., 2008). Intrigu-
ingly, ictal SPECT during a PED episode shown hyper-perfusion over
themotor cortex and putamen (Suls et al., 2008). Based on these obser-
vations, a dysfunction of the cortico-striatal pathways has been postu-
lated to play a role in the pathophysiology of PED (Suls et al., 2008).
Our fMRImaps appear to support this hypothesis asmost of our patients
shown PED as the main motor disorder. It is likely that an altered excit-
ability of striatal-thalamo-(frontal)cortical pathway,which is the conse-
quence of a defect in glucose transport across the blood-brain barrier,
subserves the generation of both epileptic activity and PED. Given the
lack of movement disorders during fMRI, this conclusion remains spec-
ulative and warrants further investigations to be conﬁrmed.
The pathogenic role of low CSF glucose to determine GLUT1DS phe-
notype, including seizures, has been objected of intense speculations
(Arsov et al., 2012a, 2012b). The primarymechanism inGLUT1 deﬁcien-
cy seems represented by a reduced substrate delivery rather than al-
tered membrane excitability as observed in channelopathies (Arsov et
al., 2012a, 2012b). Furthermore, most likely, there is reduced availabili-
ty of interstitial medium glucose to both astrocytes and neurons, the
former of which rely on GLUT1 for their glucose uptake, unlike neurons
that utilize the transporter GLUT3 (Vannucci et al., 1997). Thus, the
astroglial glucose uptake is severely compromised being restricted by
its failure at both the blood-brain barrier and the cellular membrane.
This astroglial failure could result in a decrease in the amount of lactate
produced for subsequent delivery to the neuron (Pellerin and
Magistretti, 2004) resulting in downstream neuronal dysfunction. An
early effect of this pathogenic mechanism on the structures that ﬁrststart to mature, like thalamus, might constitute the basis of the epilepti-
formabnormalities in neuroglycopenia (Giaume et al., 2010). An altered
thalamic function, indeed, might affect the cortico-thalamic and
thalamo-cortical oscillatory networks, leading to synchronized spike-
and-wave discharges (Jones, 2001; McCormick and Contreras, 2001).
In linewith this proposedmechanism, our ﬁndings indicate an opposite
BOLD response in the thalamus (negative change) and cortico-striatal
circuit (positive change). We might hypothesize that the reduced met-
abolic activity of the thalamic regions leads to a change in the activity of
the connected cortico-striatal areas, resulting in their reduced inhibition
and hence hyper-excitation. Certainly, given the limited sample of pa-
tients investigated, further studies are needed to replicate our ﬁndings
on a larger cohort of GLUT1DS subjects.
4.1. Study limitations
The major limitation of this study is related to the number of the in-
vestigated subjects, which is justiﬁed by the rarity of this genetic disor-
der. This limitation might lead to caution in generalizing the results
outside of the group of subjects analyzed. The ﬁxed effect approach ap-
plied within the GLUT1DS cohort and between the GLUT1DS and GGE,
allows to make a comment about the speciﬁc subjects studied (only
those) but it cannot be used to obtain an inference at the population
level. However, by using a conjunction approach, based on the ﬁxed-ef-
fect model, we were able to infer that at least some proportion of the
population from which the patients came show this effect (Friston et
al., 1999), i.e. to extend our speculations to the general GLUT1DS
population.
4.2. Conclusions
In conclusion, our study provides new ﬁndings on the epileptic net-
works subserving epilepsy in GLUT1deﬁciency syndrome. Several ques-
tion, however, are unanswered and should be addressed by future
studies investigating both microstructural abnormalities in GLUT1 pa-
tients with milder form of the disease, as well as the integrity or alter-
ation of resting-state networks subserving motor and cognitive
functions.
Supplementary data to this article can be found online at http://dx.
doi.org/10.1016/j.nicl.2016.12.026.
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